http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012524278-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2010-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012524278-A |
| titleOfInvention | Histone modification patterns for clinical diagnosis and prognosis of cancer |
| abstract | The present invention relates to methods for diagnosing and providing prognosis and treatment of cancer, including but not limited to pancreatic cancer, and responsiveness to thymidylate synthase inhibitor (eg, 5-FU) treatment, comprising H3K4me2, H3K9me2 or A method comprising identifying a cancer having an altered histone modification pattern selected from the group consisting of H3K18ac is provided. [Selection] Figure 3 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016044993-A |
| priorityDate | 2009-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 734.